| 000 | 01853 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517111909.0 | ||
| 264 | 0 | _c20170313 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1872-7913 | ||
| 024 | 7 |
_a10.1016/j.ijantimicag.2016.06.016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYunivita, Vycke | |
| 245 | 0 | 0 |
_aPharmacokinetics and safety/tolerability of higher oral and intravenous doses of rifampicin in adult tuberculous meningitis patients. _h[electronic resource] |
| 260 |
_bInternational journal of antimicrobial agents _cOct 2016 |
||
| 300 |
_a415-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Intravenous |
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntibiotics, Antitubercular _xadministration & dosage |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndonesia |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPlasma _xchemistry |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aRifampin _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTuberculosis, Meningeal _xdrug therapy |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aDian, Sofiati | |
| 700 | 1 | _aGaniem, Ahmad Rizal | |
| 700 | 1 | _aHayati, Ela | |
| 700 | 1 | _aHanggono Achmad, Tri | |
| 700 | 1 | _aPurnama Dewi, Atu | |
| 700 | 1 | _aTeulen, Marga | |
| 700 | 1 | _aMeijerhof-Jager, Petra | |
| 700 | 1 | _avan Crevel, Reinout | |
| 700 | 1 | _aAarnoutse, Rob | |
| 700 | 1 | _aRuslami, Rovina | |
| 773 | 0 |
_tInternational journal of antimicrobial agents _gvol. 48 _gno. 4 _gp. 415-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijantimicag.2016.06.016 _zAvailable from publisher's website |
| 999 |
_c26330307 _d26330307 |
||